BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 25677196)

  • 1. The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism.
    Thong VD; Akkarathamrongsin S; Avihingsanon A; Theamboonlers A; Poovorawan Y; Tangkijvanich P
    Intervirology; 2015; 58(2):73-9. PubMed ID: 25677196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum HCV core antigen concentration in HCV monoinfection and HCV/HIV coinfection].
    Łucejko M; Grzeszczuk A; Jaroszewicz J; Flisiak R
    Pol Merkur Lekarski; 2013 Aug; 35(206):72-6. PubMed ID: 24052984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan.
    Agha S; Tanaka Y; Saudy N; Kurbanov F; Abo-Zeid M; El-Malky M; Khalaf M; Ohta N; Yoshizawa H; Mizokami M
    J Med Virol; 2004 Jun; 73(2):216-22. PubMed ID: 15122795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis.
    Mederacke I; Potthoff A; Meyer-Olson D; Meier M; Raupach R; Manns MP; Wedemeyer H; Tillmann HL
    J Clin Virol; 2012 Feb; 53(2):110-5. PubMed ID: 22177274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection.
    Berger A; von Depka Prondzinski M; Doerr HW; Rabenau H; Weber B
    J Med Virol; 1996 Apr; 48(4):339-43. PubMed ID: 8699166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam.
    Nguyen TT; Lemee V; Bollore K; Vu HV; Lacombe K; Thi XLT; Luong QA; Dubos C; Plantier JC; Thi HD; Laureillard D; Lemoine M; Tuaillon E
    BMC Infect Dis; 2018 Dec; 18(1):622. PubMed ID: 30514229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.
    Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M; Conway B; Robaeys G; Swan T; Cloherty G; Marks P; Grebely J; Dore GJ; Applegate TL
    J Clin Virol; 2017 Jul; 92():32-38. PubMed ID: 28521211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania.
    Mohamed Z; Mbwambo J; Shimakawa Y; Poiteau L; Chevaliez S; Pawlotsky JM; Rwegasha J; Bhagani S; Taylor-Robinson SD; Makani J; Thursz MR; Lemoine M
    J Int AIDS Soc; 2017 Sep; 20(1):21856. PubMed ID: 28953324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
    Chary A; Winters MA; Eisen R; Knight TH; Asmuth DM; Holodniy M
    J Med Virol; 2012 Mar; 84(3):431-7. PubMed ID: 22246828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes.
    Behzadpour D; Ahmadi Vasmehjani A; Mousavi Nasab SD; Ahmadi NA; Baharlou R
    Pathog Glob Health; 2016; 110(7-8):310-315. PubMed ID: 27830997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus core antigen: A potential alternative to HCV RNA testing among persons with substance use disorders.
    Talal AH; Chen Y; Zeremski M; Zavala R; Sylvester C; Kuhns M; Brown LS; Markatou M; Cloherty GA
    J Subst Abuse Treat; 2017 Jul; 78():37-42. PubMed ID: 28554601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Platelet Polymorphism can be a genetic marker associated with HIV/HCV coinfection.
    Grotto RM; Picelli N; de Souza Ldo R; Silva GF; Ferrasi AC; Silveira LV; Pardini MI
    J Med Virol; 2015 Oct; 87(10):1677-81. PubMed ID: 25976501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons.
    Blackard JT; Smeaton L; Hiasa Y; Horiike N; Onji M; Jamieson DJ; Rodriguez I; Mayer KH; Chung RT
    J Infect Dis; 2005 Jul; 192(2):258-65. PubMed ID: 15962220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of hepatitis C virus antigen in hemodialysis patients].
    Wu RH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):232-4. PubMed ID: 20104788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
    Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
    J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea.
    Lim DH; Jeong JY; Nam S; Choi J; Kwon HC; Yoon YB; Kim Y; Chin B
    J Korean Med Sci; 2021 Nov; 36(46):e308. PubMed ID: 34845874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study.
    Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J;
    J Viral Hepat; 2015 Sep; 22(9):708-17. PubMed ID: 25580520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients.
    Long L; Shen T; Gao J; Duan Z; Liang H; Lu F
    BMC Infect Dis; 2014 Nov; 14():577. PubMed ID: 25371245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
    Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D
    J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.